Centro Integral Oncologico Clara Campal

Madrid, Spain
Cancer treatment center in Madrid
C. de Oña, 10, 28050 Madrid

About Centro Integral Oncologico Clara Campal


"En lo que se refiere al tratamiento, además de las técnicas más avanzadas de radiología, HM CIOCC cuenta con la unidad de investigación traslacional, que posibilita un abordaje personalizado de cada tipo de tumor. Ejemplos de servicios de máximo nivel en este sentido son la Unidad de Radiología de la Mujer o el Servicio de Oncología Radioterápica, con tres aceleradores lineales -uno de ellos casi único en España, que permite hacer cirugía intra y extracraneal-, un quirófano inteligente y braquiterapia. HM CIOCC también cuenta con un área dedicada a investigación, tanto el Laboratorio de Dianas Terapéuticas como en el Servicio de Oncología Radioterápica."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
69
Genentech, Inc.
14
Pfizer
8
Incyte Corporation
7
SOLTI Breast Cancer Research Group
7
Seagen Inc.
7
Centro Nacional de Investigaciones Oncologicas CARLOS III
4
Grupo Hospital de Madrid
4
Bayer
3
BioNTech SE
3
Boehringer Ingelheim
3
Total Rows: 74

Clinical Trials at Centro Integral Oncologico Clara Campal


During the past decade, Centro Integral Oncologico Clara Campal conducted 147 clinical trials. In the 10-year time frame, 147 clinical trials started and 68 clinical trials were completed, i.e. on average, 46.3% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 39 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years232317171919202023231616161613133311558812121111131366Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
2007-11-21
2016-05-20
Completed
86
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
2007-09-01
2009-10-01
Terminated
153
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
2009-03-01
2013-04-09
Completed
861
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors
2010-11-09
2018-04-23
Completed
66
Pazopanib as Single Agent in Advanced NETs
2011-01-26
2015-03-15
Completed
44
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
2011-11-28
2017-12-15
Completed
1,297
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804

Rows per page:

1–100 of 212

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centro Integral Oncologico Clara Campal" #1 sponsor was "Hoffmann-La Roche" with 69 trials, followed by "Genentech, Inc." with 14 trials sponsored, "Pfizer" with 8 trials sponsored, "Incyte Corporation" with 7 trials sponsored and "SOLTI Breast Cancer Research Group" with 7 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 74 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Integral Oncologico Clara Campal" #1 collaborator was "Breast International Group" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 54 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 69Hoffmann-La Roche: 69Genentech, Inc.: 14Genentech, Inc.: 14Pfizer: 8Pfizer: 8Incyte Corporation: 7Incyte Corporation: 7SOLTI Breast CancerResearch Group: 7SOLTI Breast CancerResearch Group: 7Seagen Inc.: 7Seagen Inc.: 7Centro Nacional deInvestigacionesOncologicas CARLOS III:4Centro Nacional deInvestigacionesOncologicas CARLOS III:4Grupo Hospital de Madrid: 4Grupo Hospital de Madrid: 4Bayer: 3Bayer: 3BioNTech SE: 3BioNTech SE: 3

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 5Breast International Group: 5Bristol-Myers Squibb: 4Bristol-Myers Squibb: 4Merck Sharp & Dohme LLC: 3Merck Sharp & Dohme LLC: 3European Network ofGynaecologicalOncological Trial Groups(ENGOT): 2European Network ofGynaecologicalOncological Trial Groups(ENGOT): 2Fundación PúblicaAndaluza para laInvestigación de Málagaen Biomedicina y Salud:2Fundación PúblicaAndaluza para laInvestigación de Málagaen Biomedicina y Salud:2Genmab: 2Genmab: 2Merck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2Novartis: 2Novartis: 2Pfizer: 2Pfizer: 2Roche Pharma AG: 2Roche Pharma AG: 2

Clinical Trials Conditions at Centro Integral Oncologico Clara Campal


According to Clinical.Site data, the most researched conditions in "Centro Integral Oncologico Clara Campal" are "Breast Cancer" (21 trials), "Ovarian Cancer" (15 trials), "Solid Tumors" (14 trials), "Neoplasms" (9 trials) and "Colorectal Cancer" (8 trials). Many other conditions were trialed in "Centro Integral Oncologico Clara Campal" in a lesser frequency.

Clinical Trials Intervention Types at Centro Integral Oncologico Clara Campal


Most popular intervention types in "Centro Integral Oncologico Clara Campal" are "Drug" (191 trials), "Biological" (21 trials), "Other" (6 trials), "Genetic" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (33 trials), "Placebo" (24 trials), "Paclitaxel" (19 trials), "Bevacizumab" (17 trials) and "Gemcitabine" (15 trials). Other intervention names were less common.

Clinical Trials Genders at Centro Integral Oncologico Clara Campal


The vast majority of trials in "Centro Integral Oncologico Clara Campal" are 176 trials for "All" genders, 29 trials for "Female" genders and 7 trials for "Male" genders.

Clinical Trials Status at Centro Integral Oncologico Clara Campal


Currently, there are NaN active trials in "Centro Integral Oncologico Clara Campal". undefined are not yet recruiting, 49 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 101 completed trials in Centro Integral Oncologico Clara Campal, undefined suspended trials, and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Integral Oncologico Clara Campal, 86 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 86Phase 1: 86Phase 2: 82Phase 2: 82Phase 3: 60Phase 3: 60Phase 4: 5Phase 4: 5Not Applicable: 3Not Applicable: 3Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 101Completed: 101Recruiting: 49Recruiting: 49Active, not recruiting: 31Active, not recruiting: 31Terminated: 22Terminated: 22Unknown status: 8Unknown status: 8Withdrawn: 1Withdrawn: 1